Pacific Biosciences of California Inc reports results for the quarter ended in March - Earnings Summary

Pacific Biosciences of California

02/05/2023 23:00

* Pacific Biosciences of California Inc  PACB.OQ  reported a
quarterly adjusted loss of 36 cents​​ per share for the quarter
ended in March. The mean expectation of eight analysts for the
quarter was for a loss of 33 cents per share.
    * Revenue rose 20.3% to $39.90 million from a year ago;
analysts
expected $34.38 million. 
    * Pacific Biosciences of California Inc's reported EPS for
the
quarter was a loss of 36 cents​.
    * The mean earnings estimate of analysts had risen by
about 8.1%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Pacific Biosciences of California Inc shares had fallen
by 2.3%
this quarter and gained 38.3% so far this year.
    * The company reported a quarterly loss of $88.02 million.
    * Wall Street's median 12-month price target for Pacific
Biosciences of California Inc is $12.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
2 at 10:00 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.33          -0.36          Missed
 Dec. 31 2022      -0.36          -0.37          Missed
 Sep. 30 2022      -0.33          -0.34          Missed
 Jun. 30 2022      -0.32          -0.32          Met